Enhancement of Cellular Immunity in Melanoma Patients Immunized with a Peptide from MART-1/Melan A

PURPOSE: In this study, we tested the effectiveness of a melanoma-associated antigen–derived peptide, MART-1(27–35), in eliciting cellular immune responses in vivo in the context of a phase I active immunization protocol. This peptide (AAGIGILTV) corresponds to residues 27–35 from the nonmutated mel...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Cormier, Janice N., Salgaller, Michael L., Prevette, Tracy, Barracchini, Kathleen C., Rivoltini, Licia, Restifo, Nicholas P., Rosenberg, Steven A., Marincola, Francesco M.
Format: Artigo
Idioma:Inglês
Publicat: 1997
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2597550/
https://ncbi.nlm.nih.gov/pubmed/9072306
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars